393 filings
8-K
BIOL
Biolase Inc
19 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:13pm
8-K
BIOL
Biolase Inc
21 Mar 24
Biolase Reports Full-year 2023 Results; Expects Continued Revenue Growth In 2024
4:05pm
8-K
BIOL
Biolase Inc
5 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:05am
8-K
BIOL
Biolase Inc
27 Feb 24
Other Events
4:14pm
8-K
BIOL
Biolase Inc
21 Feb 24
Other Events
7:01am
8-K
yu2a22pg5dn h0qhnjs
15 Feb 24
BIOLASE, Inc. Announces Pricing of $7.0 Million Public Offering
5:15pm
8-K
g9rtkw4ehxv
7 Feb 24
Results of Operations and Financial Condition
6:04am
8-K
ordbxx4a
29 Jan 24
Biolase Reports Unaudited Revenue Growth for Full Year 2023 and Provides
5:01pm
8-K
muyrpszfoiyce0mvnqo9
29 Dec 23
Departure of Directors or Certain Officers
4:05pm
8-K
10wyp2g7u mqq
8 Dec 23
Biolase, Inc. Announces Pricing of $1.4 Million Registered Direct
9:25am
8-K
5wyakqqot4
17 Nov 23
Entry into a Material Definitive Agreement
4:17pm
8-K
rwe9cprb nj2xltx
9 Nov 23
Results of Operations and Financial Condition
4:20pm
8-K
ouoptv8b
18 Sep 23
BIOLASE Inc. Announces Pricing of $4.5 Million
4:59pm
8-K
p5n0zn
15 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:02am
8-K
0etf7tj6sh umhrjdll
10 Aug 23
Biolase Reports Record Consumable Sales As Total Second Quarter Revenue Increases 17% Year Over Year
4:07pm
8-K
b54minaq8 p82aqs
26 Jul 23
Biolase Announces 1-FOR-100 Reverse Stock Split
4:38pm
8-K
0zczifzdx
22 Jun 23
Changes in Registrant's Certifying Accountant
7:31pm
8-K
6dpng2gs7q b7bs4ow3
13 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:09pm
8-K
ajqxatryqz4szf3d z5
6 Jun 23
Biolase Announces Distribution of Series I Preferred Stock
4:05pm
8-K
ob3drn
26 May 23
BIOLASE Inc. Announces Pricing of $4.5 Million
4:06pm